| | | | | | | |
 | MODERNA, INC. | 4.78% | -0.29% | -41.07% | -36.34% | 916.16% | 56 820 |
| IQVIA HOLDINGS INC. | -0.92% | 2.58% | -23.80% | -13.01% | 33.78% | 41 072 |
 | LONZA GROUP AG | 2.00% | 4.30% | -31.83% | -21.00% | 55.40% | 39 547 |
| SEAGEN INC. | 1.63% | 1.69% | 16.31% | 13.62% | 163.09% | 32 570 |
 | CELLTRION, INC. | 0.28% | 1.99% | -9.60% | -32.00% | -4.85% | 19 048 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.41% | -0.31% | -12.78% | -12.87% | 105.40% | 17 621 |
| ICON PUBLIC LIMITED COMPANY | -1.70% | -0.36% | -31.22% | -1.32% | 38.38% | 17 616 |
 | PHARMARON BEIJING CO., LTD. | 0.55% | 0.87% | 1.66% | -33.82% | 320.16% | 16 084 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 0.74% | 6.94% | -9.78% | -40.35% | 124.32% | 14 097 |
| BIO-TECHNE CORPORATION | 1.71% | 0.39% | -31.85% | -22.33% | 68.48% | 13 600 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.31% | -3.00% | -41.90% | -41.25% | 52.38% | 10 871 |
| QIAGEN N.V. | 1.10% | 5.29% | -14.14% | -2.67% | 17.28% | 10 736 |
| UNITED THERAPEUTICS CORPORATION | 0.88% | -2.17% | 10.01% | 28.73% | 189.72% | 10 674 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | -0.27% | 1.05% | 5.45% | 45.76% | 235.92% | 10 352 |
 | GENSCRIPT BIOTECH CORPORATION | 1.61% | 4.79% | -17.54% | -16.08% | 45.01% | 7 656 |
| | | | | | | |
| | Durchschnitt | 1.07% | 1.58% | -15.47% | -12.33% | 157.38% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 1.46% | 1.59% | -19.22% | -15.96% | 241.19% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
